| Dr Naseem Banu Sharieff, MD | |
|
7525 Greenway Center Dr, Suite 105, Greenbelt, MD 20770-3509 | |
| (301) 313-0425 | |
| (301) 313-0435 |
| Full Name | Dr Naseem Banu Sharieff |
|---|---|
| Gender | Female |
| Speciality | Pediatrics |
| Location | 7525 Greenway Center Dr, Greenbelt, Maryland |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316976194 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | D30002 (Maryland) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Naseem Banu Sharieff, MD 7525 Greenway Center Dr, Suite 105, Greenbelt, MD 20770-3509 Ph: (301) 313-0425 | Dr Naseem Banu Sharieff, MD 7525 Greenway Center Dr, Suite 105, Greenbelt, MD 20770-3509 Ph: (301) 313-0425 |
News Archive
Diabetes and high BMI (a BMI over 25 kg/m2) were the cause of 5.6% of new cancer cases worldwide in 2012 – equivalent to 792600 cases, according to the first study to quantify the proportion of cancers attributable to diabetes and high BMI published in The Lancet Diabetes & Endocrinology journal.
A large new analysis of DNA from thousands of patients has uncovered several underlying gene networks with potentially important roles in autism.
The New York Times examines several products being studied in clinical trials that researchers hope will one day prevent sexual transmission of HIV. The newspaper describes the ongoing trials of a vaginal microbicide gel containing the antiretroviral tenofovir which was found to reduce the risk of HIV infection in women by 39 percent, writing, "[o]ther clinical trials will report their results in 2011 and 2012 and, if all goes well, researchers hope to have a product or two ready to enter the market by 2013."
Scientists have identified the gene essential for survival of antibody-producing cells, a finding that could lead to better treatments for diseases where these cells are out of control, such as myeloma and chronic immune disorders.
Medtronic, Inc. today announced that the company has received CE (Conformité Européenne) Mark approval for Medtronic Deep Brain Stimulation (DBS) Therapy in Europe as adjunctive treatment for partial-onset seizures in adults with medically refractory epilepsy. DBS therapy for epilepsy delivers controlled electrical pulses to a target in the brain called the anterior nucleus of the thalamus, which is part of a circuit involved in seizures.
› Verified 2 days ago
Dr. Folami Nailah Duncan, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 7401 Greenbelt Rd, Greenbelt, MD 20770 Phone: 301-982-5437 | |
Dr. Leia Joyce Lautzenheiser, DO Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 7401 Greenbelt Rd, Greenbelt, MD 20770 Phone: 301-982-5437 | |
Todd Robert Christiansen, MD Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 7474 Greenway Center Dr, Suite 730, Greenbelt, MD 20770 Phone: 301-982-3437 | |
Dr. Gwendolyn Virginia Youngblood, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 7525 Greenway Center Dr, Suite 311, Greenbelt, MD 20770 Phone: 301-441-4555 Fax: 301-441-3420 | |
Danita Lorraine Tucker-powell, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 7525 Greenway Center Drive Suite 110, Greenbelt, MD 20770 Phone: 301-220-1200 Fax: 301-474-5590 | |
Dr. Carrie Golitko, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 7401 Greenbelt Rd, Pm Pediatrics, Greenbelt, MD 20770 Phone: 301-982-5437 |